OSCR · Oscar Health, Inc.
$30.84
+1.07 (+3.59%)
At close · Sep 30
View the 10-K filed Feb 13, 2026
Return incl. dividend (before tax)
Customer concentration
— top customer 93% of revenue
One customer — 93% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, 93% of premiums were earned directly from CMS and 7% were from our members.”
Market Cap
$9.14B
Shares
308.64M
Volume · Sep 30
5.45M
Avg daily vol (3M)
5.31M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$30.84
Open$29.75
Day$29.52–30.99
52W close$10.85–33.81
Avg vol 30d5.3M
Short int17.8M · 5.8% float · 3.7d
Short vol41%
Last earningsAug 6, 2026
DataMar 2021–Sep 2026
Filing10-Q · Aug 7
Up next
Next earnings call
Nov 6, 2026
Est · unconfirmed
· in 5 wks
filed Aug 7, 2026
call held Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$15.32B
Trailing 12 months
Net income (TTM)
$550.74M
Trailing 12 months
Revenue growth YoY
+70.4%
Year over year
Operating margin
4.1%
Trailing 12 months
P / E (TTM)
20.5
Trailing earnings · reciprocal yield 4.9%
FCF yield
47.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+30.5%
Year over year · more shares
Price change (1Y)
+55.6%
Trailing year
Short interest
5.8%
Latest settlement · 3.7 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+42%
above
Price vs 50-day avg
+0%
above
RSI (14)
50
neutral
MACD trend
Negative
52-week position
87%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+3%
trailing
6-month return
+112%
trailing
YTD return
+115%
this year
Relative strength
+100%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $31 › 200d $22 — 50d above 200d
Institutional flow
Accumulating
+21% holders QoQ · +127 funds added
Insider flow
Distributing
Net -$23.4M over 90 days · 100% sells
Short interest
Rising
5.76% of float · ▲ +8.6% MoM · 3.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
409 holders — near 3-yr high, broad support
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
+28%
Y/Y
EPS growth
−1790%
Y/Y
Valuation
P/E 20.4
below peers
Quant / Vol
risk profile
Volatility
70%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 6, 2026
Medical Loss Ratio
· Full Year 2026
Initiated
81.5% – 82.5%
SG&A Expense Ratio
· Full Year 2026
Initiated
15.6% – 16.1%
Guided vs delivered
· last 1 settled
Total Revenue
Full Year 2024 Outlook
guided $8.3B – $8.4B
$9.18B
Beat +9.9%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+42%
Bullish
Price vs 50-day avg
+0%
Bullish
RSI (14)
50
Neutral
MACD trend
Negative
Bearish
52-week position
87%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $31 › 200d $22 — 50d above 200d
Institutional flow
Accumulating
+21% holders QoQ · +127 funds added
Insider flow
Distributing
Net -$23.4M over 90 days · 100% sells
Short interest
Rising
5.76% of float · ▲ +8.6% MoM · 3.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
409 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $11
Now $31 · 87%
Range high $34
vs 200-day avg +42%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| MLR | 79.2% | Three Months Ended June 30, 2026 filing | — |
| SG&A expense ratio | 14.2% | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSCR
this stock
Oscar Health, Inc.
|
$9.14B | +114.6% | +27.5% | 20.4 | 5.8% |
|
UNH
Unitedhealth Group Inc
|
$338.03B | +11.2% | +11.8% | — | 1.5% |
|
CVS
CVS HEALTH Corp
|
$110.82B | +8.0% | +7.8% | 22.9 | 1.3% |
|
ELV
Elevance Health, Inc.
|
$85.90B | +10.9% | +12.5% | 17.5 | 2.5% |
|
CI
Cigna Group
|
$71.06B | -1.2% | +11.2% | 11.1 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSCR | +1.0% | +3.4% | +112.1% | +2.9% | +114.6% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +1.7% | +3.3% | +99.9% | +3.5% | +102.8% |
Key facts
CIK
1568651
CUSIP
687793109
13F (30d)
11 filings
9 filers
Visit website
Investor relations